Moody’s affirms Centra Health’s ‘A2’ bond rating

Moody’s Investors Service has affirmed the “A2” rating assigned to Va.-based Centra Health’s bonds issued through the Lynchburg Industrial Development Authority, affecting $154.8 million of outstanding debt.

Advertisement

The rating affirmation is based on several factors, including Centra’s leading volume in its primary service area and successful management of multiple new projects.

The rating is offset by the system’s weak payer mix, risky capital structure and relative uncertainty surrounding the financial outcomes of its new projects.

The outlook is stable, reflecting Centra’s consistent operating metrics in fiscal year 2014 and Moody’s expectation that margins should be sustained.

More articles on finance:
ICD-10 aftershocks: 4 challenges every CFO can expect in the wake of go-live
Bankrupt Georgia hospital accused of putting patients at risk
S&P revises AtlantiCare Regional Medical Center’s outlook to positive

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.